Patents by Inventor Mathew Longiaru

Mathew Longiaru has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5837818
    Abstract: A synthetic gene which codes for at least one epitope from the immunodominant conserved region of HTLV-I env. gp 21 as well as hybrid genes utilizing the synthetic gene in conjunction with other epitopes from HTLV-Ienv.
    Type: Grant
    Filed: August 2, 1996
    Date of Patent: November 17, 1998
    Assignee: Roche Diagnostic Systems, Inc.
    Inventors: Deborah A. Buonagurio, Mathew Longiaru
  • Patent number: 5693755
    Abstract: A synthetic gene which codes for at least one epitope from the immunodominant conserved region of HTLV-I env. gp 21 as well as hybrid genes utilizing the synthetic gene in conjunction with other epitopes from HTLV-Ienv.
    Type: Grant
    Filed: October 21, 1994
    Date of Patent: December 2, 1997
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Deborah Anne Buonagurio, Mathew Longiaru
  • Patent number: 5232829
    Abstract: The present invention relates to the synthesis of amplified biotin-labelled DNA target sequences of Chlamydia trachomatis by polymerase chain reaction techniques and the detection of such sequences by a microtiter plate having plurality of wells and having bound thereto oligonucleotide capture probe complementary to said target sequence.
    Type: Grant
    Filed: September 29, 1989
    Date of Patent: August 3, 1993
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Mathew Longiaru, Sheryl B. Silver, Michael A. Sulzinski